• Title/Summary/Keyword: Triple-antibiotics

Search Result 20, Processing Time 0.021 seconds

Triple antibiotics와 관련한 치아 변색의 예방 (Prevention of tooth discoloration associated with triple antibiotics)

  • 김보나;송민주;신수정;박정원
    • Restorative Dentistry and Endodontics
    • /
    • 제37권2호
    • /
    • pp.119-122
    • /
    • 2012
  • Regenerative endodontics has a potential to heal a partially necrotic pulp, which can be beneficial for the continued root development and strengthening of immature teeth. For this purpose, triple antibiotic mixture of ciprofloxacin, metronidazole, and minocycline was recommended as intracanal medicament in an attempt to disinfect the root canal system for revascularization of a tooth with a necrotic pulp. However, discoloration of the tooth was reported after applying this. This case shows the idea for preventing the tooth discoloration using a delivery syringe to avoid the contact between the clinical crown and the antibiotics.

치수 괴사된 미성숙 영구치에서 Retro MTA를 이용한 변색 없는 재생적 근관치료 : 증례 보고 (Regenerative Endodontic Treatment Without Discoloration of Infected Immature Permanent Teeth Using Retro MTA : Two Case Reports)

  • 김유정;김선미;최남기
    • 대한소아치과학회지
    • /
    • 제41권4호
    • /
    • pp.335-343
    • /
    • 2014
  • 재생적 근관치료는 치수 괴사를 보이는 미성숙 영구치 치료에 있어서 괴사된 치수를 치유하고 계속되는 치근의 발달을 유도할 수 있다. 그러나 여기에는 몇 가지 단점과 불리한 결과들이 있다. 이 중 재생적 근관치료에 가장 큰 임상적 부작용은 minocycline과 MTA에 의한 변색이다. 본 증례에서는 재생적 근관치료 후에 나타나는 치관 변색을 방지하기 위해 minocycline을 clindamycin으로 대체한 triple antibiotics와 칼슘 지르코늄 알루민산염 시멘트인 Retro MTA를 사용하였다. 치수 괴사된 미성숙 영구치에서 근관 와동 형성 및 근관 세척 후 수정된 triple antibiotics를 적용하고, 혈병 또는 콜라겐 스펀지를 스캐폴드(scaffold)로 하여 Retro MTA로 근관을 폐쇄하였다. 정기적인 검진 결과 미성숙 영구치의 치근 성장 및 정상적인 치아 주위 조직들이 관찰되었으며, 치관 변색 없이 모두 양호한 치유 결과를 얻었다.

미성숙영구치의 복합항생제 적용에 의한 변색의 처치: 증례보고 (TREATMENT OF TOOTH DISCOLORATION ASSOCIATED WITH TRIPLE ANTIBIOTIC THERAPY: CASE REPORTS)

  • 박소연;김영재;김정욱;장기택;이상훈;김종철;한세현;현홍근
    • 대한소아치과학회지
    • /
    • 제39권1호
    • /
    • pp.43-50
    • /
    • 2012
  • 괴사된 미성숙영구치의 치수치료에 있어서 치수의 재혈관화를 통해 치근단 발육 및 치근형성을 지속하려는 개념이 소개됨으로써 현재 미성숙영구치의 치수치료의 대안으로 제시되고 있다. 이러한 치근단 염증을 가진 미성숙 영구치의 재혈관화를 위해서는 가장 중요한 것이 근관내 감염된 부분을 확실히 제거하는 살균(disinfection)이다. 근관 내 감염은 여러 세균의 복합작용으로 일어나기 때문에 철저한 살균에 사용되는 약제의 조합은 다양한 범위의 균주를 모두 제거 가능해야한다. Metronidazole(MN), ciprofloxacin(CF), minocycline(MC)의 세 가지 복합항생제가 약제로 사용되고 있으나 이 복합항생제 적용 후 치관변색을 일으키는 사례가 보고되고 있다. 이러한 치관변색은 항생제의 성분 중 MC에 의한 것으로 여겨지고 있으며, 본 증례에서는 복합항생제 적용에 의해 야기된 치관변색의 증례를 소개하고 이를 표백술로 처치하여 최종 수복한 증례를 보고하였다. 복합항생제 적용을 통해 미성숙영구치의 치수치료에 새로운 패러다임을 제시한 것은 분명하지만 치관변색 등의 부작용이 있음을 인지하고 치관변색을 사전에 예방하고 최소화하기 위해 다양한 방법이 강구되어야 할 것이다.

계유내(鷄由來) Escherichia coli의 항생물질내성(抗生物質耐性)및 R 인자(因子)의 분포(分布) (Antibiotic Resistance of Escherichia coli Isolated from Hens)

  • 탁련빈
    • 대한수의학회지
    • /
    • 제17권1호
    • /
    • pp.1-4
    • /
    • 1977
  • Two hundred and twenty-seven strains of Escherichia coli isolated from 25 hens (12 hens received tetracycline neomycin and sulfadimethoxine, and 13 hens not received antibiotics) were studied for the drug resistance and distribution of R factors. About 74 per cent of E. coli strains isolated from hens of a herd received antibiotics were resistance to tetracycline (TC) streptomycin (SM), chloramphenicol (CM), kanamycin (KM), ampicillin (AP) and sulfisomidine (Su), alone or in combination thereof, but only a hen among a herd not received antibiotics excreted E. coli resistant to TC and SM. Among resistant strains, about 7% were found to be resistant to TC and SM, whereas 93% were resistant to three or more antibiotics. The most common pattern was the quadruple resistant to SM, TC, KM and Su (28.7%), and followed by triple ones to SM, TC and Su (25.3%), and SM, TC and KM (24.7%). About 84% of resistant strains carried R factors which were transferable to the recipient by conjugation.

  • PDF

소에서 분리(分離)한 Escherichia coli의 항생물질내성(抗生物質耐性) 및 전달성내성인자(傳達性耐性因子)의 분포(分布) (Susceptibility of Escherichia coli Isolated from Cattle to Some Antimicrobial Agents)

  • 박청규
    • 대한수의학회지
    • /
    • 제17권1호
    • /
    • pp.5-8
    • /
    • 1977
  • One hundred and fifty seven Escherichia coli strains isolated from 18 cattle (9 dairy cattle received penicillin, streptomycin (SM) or sulfadimethoxine for treatment of diseases and 9 Korean native cattle not received antibiotics) were studied for the drug resistance and distribution of R factors. Of 88 E. coli strains isolated from cattle not received antibiotics, only 1 strain was resistant to SM, but about 46 per cent of 69 E. coli strains isolated from cattle received antibiotics were resistant to SM, tetracycline (TC), ampicillin (AP), kanamycin (KM), chloramphenicol (CM), and sulfisomidine (Su), alone or in combination thereof. Of resistant strains, about 72% were resistant to three or more antibiotics, but 28% were found to singly resistant. The most frequent resistant pattern was triple resistance to AP, KM and Su (37.6%), and quadruple one to SM, TC, CM and Su (12.5%). About 28% of resistant strains carried R factors which were transferable to E. coli ML 1410 $NA^r$ by conjugation.

  • PDF

감염된 미성숙 영구치에서 platelet-rich fibrin과 double antibiotic paste를 이용한 치수 재혈관화 : 증례 보고 (Pulp Revascularization of Infected Immature Permanent Teeth Using Platelet-Rich Fibrin and Double Antibiotic Paste : Case Report)

  • 전상윤;이난영;이상호
    • 대한소아치과학회지
    • /
    • 제40권3호
    • /
    • pp.216-222
    • /
    • 2013
  • 감염된 미성숙 영구치의 치수치료에 있어 줄기세포의 분화를 유도하는 생활조직의 재생과 지속적인 치근형성을 도모하는 방향으로 패러다임이 전환되고 있는데, 여기에서는 소독, 스캐폴드(scaffold), 그리고 폐쇄가 중요하다. 소독을 위해 triple antibiotics가 널리 사용되고 있으며, 스캐폴드로써 기존의 혈병대신 platelet-rich fibrin의 사용이 보고되었다. 본 증례보고에서는 치외치 파절에 의해 치수가 감염된 미성숙 영구치에서 platelet-rich fibrin을 스캐폴드로써 이용한 치수 재혈관화를 시행하였다. 발수와 근관세척 후 첫 증례에서 국소적 항생제의 적용 없이 platelet-rich fibrin을 단독 사용하였고 두 번째와 세 번째 증례에서는 국소적 항생제 적용 후 platelet-rich fibrin을 적용하였는데 모두 양호한 치유 결과를 얻었다.

Metallo-β-lactamase 생성 Pseudomonas aeruginosa의 시험관내 항균제 병합요법에 대한 연구 (In vitro Antimicrobial Combination Therapy in Metallo-β-lactamase Producing Pseudomonas aeruginosa)

  • 홍승복
    • 대한임상검사과학회지
    • /
    • 제38권3호
    • /
    • pp.166-172
    • /
    • 2006
  • Metallo-${\beta}$-lactamase (MBL) can hydrolyze all ${\beta}$-lactams except monobactams and frequently coexists with various antibiotic resistance genes such as aminoglycoside resistance, sulfonamide resistance gene, etc. Therefore, the effective antibiotics against infections by these bacteria are markedly limited or can't even be found. We tried to search in-vitro antimicrobial combinations with synergistic effects for a VIM-2 type MBL producing Pseudomonas aeruginosa, isolated from clinical specimen. On the selection of antibiotic combinations with synergistic effects, we performed a one disk synergy test, modified Pestel's method, in agar without aztreonam (AZT). The bacteriostatic synergistic effects of this tests were scored as $S_1$ (by susceptibility pattern in agar without antibiotics), $S_2$ (by the change of susceptibility in agar with or without antibiotics) and $S_3$ ($S_1$ + $S_2$) and was classified into weak (1 point), moderate (2 points) and strong (3 points) by $S_3$ score. Subsequently, we carried out the time-killing curve for the antibiotic combinations with the strong synergistic bacteriostatic effect. One VIM-2 type MBL producing P. aeruginosa confirmed by the PCR showed all resistance against all ${\beta}$-lactams except AZT, aminoglycoside and ciprofloxacin. In the one disk synergy test, this isolate showed a strong bacteriostatic synergistic effect for the antibiotic combination of AZT and piperacillin-tazobactam (PIP-TZP) or AZT and amikacin (AN). On the time-killing curve after six hours of incubation, the colony forming units (CFUs/mL) of this bacteria in the medium broth with both combination antibiotics were decreased to 1/18.7, 1/17.1 of the least CFUs of each single antibiotics. The triple antibiotic combination therapy including AZT, PIP-TZP and AN was shown to be significantly synergistic after 8 hrs of exposure. In a VIM-2 MBL producing P. aeruginosa with susceptibility for AZT, the triple antibiotic combination therapy including AZT, PIP-TZP and AN may be considered as an alternative antibiotics modality against the infection by some MBL type. But the antimicrobial combination therapy for many more MBL producing isolates is essential to know as soon as possible for the selection of effective treatment against the infection by this bacteria.

  • PDF

버섯의 항생물질(抗生物質) (Antibiotics from Mushrooms)

  • 황병호
    • Journal of Forest and Environmental Science
    • /
    • 제22권1호
    • /
    • pp.83-100
    • /
    • 2006
  • Antibiotics which produced by mushrooms discovered for last 40 years were described. Any antibiotic has not been used as infectious disease remudy but will be used as physiological active substance in near future. The antibiotic of mushrooms have not been published much in papers and do not have various finds of structures, compared to those of Streptomyces. Triple bond having compounds, terpenoid compounds aromatic compounds and some other compound have been known. These compounds are not dissolved well in water and mainly fat-soluble, except for cordycepin. Also, they are generally neutral, and some of them are acidic and almost none of them are basic compounds. However, acetylene and terpenoid compounds are the characteristic compounds of mushroom, and are not found in other microorganisms and plants. Especially, there are various terpenoid compounds in mushrooms. These metabolites of mushrooms were not used as antibiotic, but are interested as physiological active substance, such as enzyme inhibitor and immunomodulator. To promote studying on the antibiotics of mushroom, new screening methods must be developed, because strain belonged to the different genus produces different antibiotics, even though mushrooms belonged to the same genus and species. It is also known that mushrooms collected in different areas produce different antibiotics. Now, it is difficult to separate each pure compound from mushroom. It is important to find mushrooms which is impossible to cultivate artificially, or grow in the back land where is difficult to collect. Thousands of mushrooms grow on earth now, so that which species will be screened if not known. The biochemical and mycological study for usability of the metabolites of mushrooms is thought, as one of the important research areas, must be performed.

  • PDF

Triple antibiotic paste: momentous roles and applications in endodontics: a review

  • Parhizkar, Ardavan;Nojehdehian, Hanieh;Asgary, Saeed
    • Restorative Dentistry and Endodontics
    • /
    • 제43권3호
    • /
    • pp.28.1-28.16
    • /
    • 2018
  • This study investigated the latest findings and notions regarding 'triple antibiotic paste' (TAP) and its applications in dentistry, particularly endodontics. TAP is a combination of 3 antibiotics, ciprofloxacin, metronidazole, and minocycline. Despite the problems and pitfalls research pertaining to this paste has unveiled, it has been vastly used in endodontic treatments. The paste's applications vary, from vital pulp therapy to the recently introduced regeneration and revascularisation protocol. Studies have shown that the paste can eliminate the root canal microorganisms and prepare an appropriate matrix for further treatments. This combination is able to remove diverse groups of obligate and facultative gram-positive and gram-negative bacteria, providing an environment for healing. In regeneration protocol cases, this allows the development, disinfection, and possible sterilization of the root canal system, so that new tissue can infiltrate and grow into the radicular area. Moreover, TAP is capable of creating a discipline in which other wanted and needed treatments can be successfully performed. In conclusion, TAP, as an antibacterial intracanal medication, has diverse uses. Nevertheless, despite its positive effects, the paste has shown drawbacks. Further research concerning the combined paste and other intracanal medications to control microbiota is a must.

치근단 치주염을 가진 미성숙 제1대구치의 치수 재혈관화 : 증례 보고 (PULP REVASCULARIZATION OF IMMATURE FIRST PERMANENT MOLARS WITH APICAL PERIODONTITIS : CASE REPORT)

  • 전혜진;양연미;김재곤;백병주
    • 대한소아치과학회지
    • /
    • 제39권2호
    • /
    • pp.192-198
    • /
    • 2012
  • 치수 재혈관화 술식은 항생제를 이용하여 근관 내 감염된 조직을 무균 상태로 만들면 치근단에 존재하는 자가 재생 능력과 다분화 능력을 가진 줄기 세포가 미완성 치근을 가진 미성숙 영구치의 치수 재생을 유도한다는 개념이 적용된 것이다. 이 술식은 치근의 길이와 두께가 증가하며 치근단의 폐쇄가 이루어진다. 비정상적으로 근관이 얇거나 만곡이 심해 전통적인 근관 치료시 어려움이 예상되는 경우, 전신 질환 등으로 인해 진정 요법을 시행하기 어려운 경우, 그리고 장애인와 같이 협조를 구하기 어려운 경우에서 치근단 치주염을 가진 미성숙 대구치의 치수 재혈관화 술식을 고려해 볼 수 있다. 본 증례는 우식으로 인해 감염된 미성숙 제1대구치의 근관 내에 ciprofloxacin, metronidazole, minocycline의 3종의 항생제를 적용하여 치수 재혈관화 술식을 시도하여 양호한 결과를 보였기에 이를 보고하고자 한다.